openPR Logo
Press release

The Intravitreal IVT Injectable Market to Gloat Over Advancement in Healthcare Marketing Technology

02-15-2022 02:57 AM CET | Health & Medicine

Press release from: Persistence Market Research

The Intravitreal IVT Injectable Market to Gloat Over

The Intravitreal IVT Injectable Market is likely to grow stupendously in the subsequent decade. With IoT in the picture, the complex medical equipment could be monitored, that too, all at a time and under one umbrella. As such, costly downtime could be avoided and predictive maintenance could be fostered. Plus, increased spending could be facilitated for disposable items like syringes, gloves, and masks.

Get Sample Copy of this Report@ https://www.persistencemarketresearch.com/samples/25906

Retinal diseases contributing heavily to the demand growth of intravitreal (IVT) injectables

Hereditary retinal diseases is the major cause of visual loss. Macular degeneration, Diabetic Retinopathy is the important and prominent cause of blindness. According to Genentech Retinal disease report, around 11 million US population are affected with age-related macular degeneration, 7.7 million people are affected with diabetic retinopathy and around 1.1 million population are affected with retinal vein occlusions.

Anti-VEGF intravitreal (IVT) injectables medication is most likely use to treat retinal disorders. Increasing prescription of anti-VEGF anticipate the growth of the intravitreal (IVT) injectables market. Many manufacturers aims to develop drugs with anti-VEGF inhibitor, as a result leading to an increase in the demand for intravitreal (IVT) injectables.

Company Profiles:

Regeneron Pharmaceuticals, Inc.
Bausch & Lomb
Novartis AG
Allergan
Alimera Sciences
ThromboGenics, Inc.
Bristol-Myers Squibb Company
Other

Request for Methodology@ https://www.persistencemarketresearch.com/methodology/25906

North America to have substantial revenue growth in intravitreal (IVT) injectables Market

North America region shown to have high growth in intravitreal (IVT) injectables market. Low vision and blindness are prevailing in the region and high prescription of anti-VEGF intravitreal (IVT) injectables medication has increases the growth of intravitreal (IVT) injectables market. It is estimated that intravitreal (IVT) injectables create an incremental $ opportunity worth US$ 4,350 Mn between 2018 and 2028.

Lucentis marketed by Roche and Eylea marketed by Regeneron in the United States, are the commonly prescribed biologics use in intravitreal (IVT) injectables. Apart from this, Avastin and Macugen are also widely used in intravitreal (IVT) injectables market. The North America region holds a significant share in intravitreal (IVT) injectables among all other regions, due to the increase in prescription of retinal biologics, high healthcare facilities and availability and usage of expensive drugs.

Access Full Report@ https://www.persistencemarketresearch.com/checkout/25906

Intravitreal (IVT) Injectables Market: Segmental Analysis

The global intravitreal (IVT) injectables market has been segmented on the basis of drug class, indication and distributional channel. On the basis of drug class, the intravitreal (IVT) injectables market has been segmented into anti-VEGF, corticosteroids, antibiotics, antivirals and antifungals. Based on indication, the intravitreal (IVT) injectables market has been segmented into diabetic retinopathy, macular degeneration, endophthalmitis, retinal vein occlusions and others.

Complete Report Details@ https://www.persistencemarketresearch.com/market-research/intravitreal-ivt-injectable-market.asp

In terms of revenue, the anti-VEGF segment is expected to have a major share in intravitreal (IVT) injectables during the forecast period as it prevents angiogenesis and also minimize the leakage of fluid that occurs due to retinal diseases. On the basis of distributional channel, the intravitreal (IVT) injectables market has been categorized into hospital pharmacies, retail pharmacies, drug stores, mail order pharmacies and others. The hospital pharmacies is expected to have high revenue growth in intravitreal (IVT) injectables, owing to the availability of biologics and increase in prescription of anti-VEGF drugs.

Related Reports:

Sterile Injectable Drugs Market - https://www.persistencemarketresearch.com/market-research/sterile-injectable-drugs-market.asp

U.S Bacterial Conjunctivitis Drugs Market - https://www.persistencemarketresearch.com/market-research/u.s-bacterial-conjunctivitis-drugs-market.asp

Contact Us:

Persistence Market Research
Address – 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com
Website – https://www.persistencemarketresearch.com

About Us:

Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers’ experience by acting as the “missing” link between “customer relationships” and “business outcomes’. The best possible returns are assured therein.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release The Intravitreal IVT Injectable Market to Gloat Over Advancement in Healthcare Marketing Technology here

News-ID: 2552392 • Views:

More Releases from Persistence Market Research

Fan-Out Wafer Level Packaging Market to Reach US$5.93 Bn by 2032: Growth Driven by Rising Demand for High-Performance Semiconductors
Fan-Out Wafer Level Packaging Market to Reach US$5.93 Bn by 2032: Growth Driven …
The global fan-out wafer level packaging (FOWLP) market is witnessing rapid expansion as the semiconductor industry continues to push the limits of performance, miniaturization, and energy efficiency. Fan-out wafer level packaging, a next-generation semiconductor packaging technology, offers significant advantages over traditional packaging techniques by enabling higher input/output (I/O) density, reduced package thickness, and enhanced electrical performance. As consumer electronics, automotive electronics, and advanced computing devices demand faster and more compact
Hydrogen Tube Trailer Market to Reach US$ 651.9 Mn by 2032: Growth Driven by Rising Hydrogen Energy Demand
Hydrogen Tube Trailer Market to Reach US$ 651.9 Mn by 2032: Growth Driven by Ris …
The global hydrogen tube trailer market is experiencing remarkable growth, fueled by the expanding hydrogen economy and increasing demand for efficient and safe hydrogen transportation solutions. As hydrogen continues to emerge as a critical component in the global energy transition toward low-carbon and renewable fuels, the need for advanced logistics infrastructure-including high-capacity tube trailers-has become increasingly essential. According to the latest study by Persistence Market Research, the global hydrogen tube trailer
Paraffin Wax Market to Reach US$9.73 Billion by 2032, Driven by Growing Demand in Packaging, Candles, and Personal Care
Paraffin Wax Market to Reach US$9.73 Billion by 2032, Driven by Growing Demand i …
The global paraffin wax market is experiencing a robust expansion, fueled by its versatile applications across a wide range of industries such as packaging, candle manufacturing, cosmetics, and pharmaceuticals. Paraffin wax, a petroleum-derived material known for its translucency, water resistance, and smooth texture, continues to be an indispensable ingredient in both industrial and consumer products. According to the latest study by Persistence Market Research, the global paraffin wax market size is
Coil Coatings Market to Reach US$5.3 Billion by 2032: Growth Driven by Expanding Construction and Automotive Sectors
Coil Coatings Market to Reach US$5.3 Billion by 2032: Growth Driven by Expanding …
The global coil coatings market is witnessing sustained growth, driven by rising demand from the construction, automotive, and appliance manufacturing industries. Coil coatings-also known as pre-painted metal coatings-are applied to metal sheets and strips before fabrication, offering enhanced durability, corrosion resistance, and aesthetic appeal. These coatings not only improve product lifespan but also reduce environmental impact by minimizing waste and VOC (volatile organic compound) emissions compared to traditional post-painting methods. According

All 5 Releases


More Releases for IVT

Intravitreal (IVT) Injectable Market Dynamics: Driving Forces Behind Market Expa …
The healthcare sector, especially in the field of ophthalmology, is witnessing significant growth due to the rising prevalence of eye diseases and advancements in injectable drug delivery systems. One of the most important developments in the treatment of retinal diseases has been the introduction of intravitreal (IVT) injectables. These injectable therapies are used to treat a range of eye conditions, such as age-related macular degeneration (AMD), diabetic retinopathy (DR), diabetic
Intravitreal (IVT) Injectable Market Transformative Innovations and Future Growt …
𝑰𝒏𝒕𝒓𝒐𝒅𝒖𝒄𝒕𝒊𝒐𝒏 The Intravitreal (IVT) injectable market has emerged as a pivotal segment in ocular therapeutics, driven by the increasing prevalence of retinal disorders and advancements in drug delivery technologies. Intravitreal injections, administered directly into the vitreous humor, have revolutionized the treatment of various ocular conditions such as age-related macular degeneration (AMD), diabetic macular edema (DME), and retinal vein occlusion (RVO). This article explores the transformative innovations shaping the IVT injectable market
Intravitreal (IVT) Injectable Market Size, Share, Industry, Forecast (2024-2031)
Market Overview: The global intravitreal injectable market is growing at a CAGR of 5.8% during the forecast period of 2024-2031. Key drivers of market growth include the increasing prevalence of chronic retinal diseases, particularly cataracts, and advancements in drug development by key manufacturers to meet patient needs. However, market growth may be hindered by the risks associated with intravitreal injections. Market Dynamics: Growing Prevalence of Cataracts: Cataracts, which are the primary cause of
The Intravitreal (IVT) Injectable Market To Prove Its Servility To Technological …
According to the most recent Persistence Market Research (PMR) report, the Intravitreal (IVT) Injectables Market will grow at a CAGR of 4.9% between 2022 and 2028, surpassing US$ 23,814.3 million in terms of market value. Growing retinal diseases are expected to boost the global intravitreal injectable market at a substantial rate over the forecast period. Millions of people are affected by retinal disorders, which commonly result in vision loss or complete
The Intravitreal IVT Injectable Market to Witness Invigorating Trends
The Intravitreal IVT Injectable Market is expected to grow on an irreversible note in the next 10 years. The future scenario would be data-driven healthcare. This would, in turn, widen the potential for enhancing treatment options. With interoperability taking the centre stage, program participants could access app blueprints, data templates, and security tools. Thus, the big data cloud would turn out to be kinetic. This would result in an upswing
The Intravitreal IVT Injectable Market to grow on an invincible note
The Intravitreal IVT Injectable Market is expected to grow by leaps and bounds in the forecast period. Nanotechnology’s medical application is on the anvil. As such, nanomedicine is an outcome of the technology operating at the molecular, atomic, or supramolecular scale. The broad application areas of nanomedicine include sensing, imaging, diagnosis, and delivery via medical devices. This would certainly keep the healthcare vertical upgraded continuously. Hereditary retinal diseases is the major